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Abbreviations: 18GA: 18 Glycyrrhetinic acid; Cx: Connexin; DAPI: 4',6-diamidino-2-phenylindole; 
EKV-P: Erythrokeratodermia variabilis et progressiva; ER: endoplasmic reticulum; ERGIC: 
endoplasmic reticulum golgi intermediate compartment; GFP: Green Fluorescent Protein; GJ :gap 
junction; KID: keratitis ichthyosis deafness syndrome; PCR: polymerise chain reaction; PI: propidium 
iodide; SERCA2b: (sarcoplasmic reticulum calcium ATPase; UPR: unfolded protein response. 
 
Abstract 
Erythrokeratodermia variabilis et progressiva (EKV-P) is caused by mutations in either the 
GJB3 (Cx31) or GJB4 gene (Cx30.3).  We identified a rare GJB3 missense mutation, 
c.134G>A (p.G45E), in two unrelated patients and investigated its cellular characteristics. 
Expression of Cx31G45E-GFP caused previously undescribed changes within HeLa cells and 
HaCaT cells, a model human keratinocyte cell line. Cx31WT-GFP localised to the plasma 
membrane, but expression of Cx31G45E-GFP caused vacuolar expansion of the endoplasmic 
reticulum (ER), the mutant protein accumulated within the ER membrane and disassembly of 
the microtubular network occurred. No ER stress responses were evoked. Cx31WT-myc-
myc-6xHis and Cx31G45E-GFP co-immunoprecipitated, indicative of heteromeric 
interaction, but co-expression with Cx31WT-mCherry, Cx26 or Cx30.3 did not mitigate the 
phenotype. Cx31 and Cx31G45E both co-immunoprecipated with Cx43, indicating the ability 
to form heteromeric connexons. WT-Cx31 and Cx43 assembled into large gap junction 
plaques at points of cell to cell contact, Cx31G45E restricted the ability of Cx43 to reach the 
plasma membrane in both HaCaT cells and HeLa cells stably expressing Cx43 where the 
proteins strongly co-localised with the vacolourised ER. Cell viability assays identified an 
increase in cell death in cells expressing Cx31G45E-GFP, which FACS analysis determined 
was necrotic. Blocking connexin channel function with 18α-Glycyrrhetinic acid did not 
completely rescue necrosis or prevent propidium iodide uptake, suggesting that expression of 
Cx31G45E-GFP damages the cellular membrane independent of its channel function. Our 
data suggests that entrapment of Cx43 and necrotic cell death in the epidermis could underlie 
the EKV skin phenotype. 
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1. INTRODUCTION  
A healthy skin barrier requires a highly ordered and tightly regulated intercellular adhesion network, 
which includes adherens junctions, tight junctions and gap junctions (GJ). GJs mediate rapid 
intercellular communication and play a key role in epidermal integrity [1]. They are composed of 
connexins (Cxs), with 21 subtypes identified in humans, ranging in size from 25 to 62 kDa, with their 
nomenclature based on their molecular mass, e.g., Cx31 is a 31kDa protein [2]. Cxs are composed of 
four transmembrane domains linked by two highly conserved extracellular loops (EL1 and EL2) with 
one variable intracellular loop and carboxyl tail [3]. Cxs follow a classic biosynthetic pathway from 
the endoplasmic reticulum (ER), where they oligomerise to form a hexameric connexon (or 
hemichannel), that is trafficked in a closed state to the plasma membrane. Hemichannels can be 
induced to open under pathological conditions, but normally accrete laterally in a closed state along 
the plasma membrane to align and dock with a neighbouring channel and form a functional GJ unit 
[1, 3]. Within normal epidermis, at least  six Cx subtypes are differentially expressed. Connexin43 
(encoded by GJA1) and Cx31 (encoded by GJB3) are expressed throughout the epidermis, while Cx26 
(encoded by GJB2), Cx30 (encoded by GJB6), Cx30.3 (encoded by GJB4) tend to be associated with 
differentiated cells in the upper layers [4-8]. The importance of connexins in the skin is illustrated by 
various disorders caused by mutations in different beta-Cx subtypes [9-16]. Erythrokeratodermia 
variabilis et progressiva (EKV-P) (Mendes da Costa, EKV-P, MIM #133200) is caused by heterozygous 
mutations in either Cx31 or Cx30.3 e.g. [17-25]. The clinical appearance of EKV-P ranges from 
temporary, fast moving erythemas to permanent red-brown hyperkeratosis (supplementary Table 
1). With the possible exception of an erythema gyratum repens-like manifestation of EKV-P caused 
by Cx30.3 mutations, a genotype-phenotype correlation is not present [20, 26]. Disease-associated 
Cx31 mutations, when expressed in HeLa cells, result in both apoptotic and necrotic cell death [27, 
28]. Several studies indicate that ER stress is involved in this process [27, 29, 30]. We describe how a 
rare EKV-associated Cx31 mutant (G45E) [20, 22, 24] causes necrotic cell death through a unique 
effect on the ER and entrapment of Cx43. We suggest that this may be a novel connexin-mediated 
human disease mechanism. 
 
2. MATERIALS AND METHODS 
2.1 Construction of tagged Cx-WT and mutant constructs 
Wild type (WT) Cx31 was inserted into the vector pEGFP-N1 (BD Biosciences, Breda, The 
Netherlands) as previously reported and a range of mutations (Cx31G45E, Cx31delG45, Cx31G45A, 
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Cx31G45K, Cx31G45S, Cx31G45Q and Cx31G45W) introduced by site directed mutagenesis (see 
supplementary methods and supplementary Table 2) [12]. Cx31WT, Cx26WT and Cx30.3WT were 
inserted into the pmCherry-N1 vector (Clontech, via Westburg BV, Leusden, The Netherlands). A 
two-step process replacing the GFP tag with a myc-myc-6xHis tag from a plasmid gifted from Thomas 
Weimbs (Addgene plasmid # 12377 [31]) was used to generate a Cx31WT-myc-myc-6xHis tagged 
construct.  
 
2.2 Cell Culture and transfection 
Cell lines, HeLa Ohio (ATTC) and HaCaT cells (CLS, Eppelheim, Germany) or HeLa cells stably 
expressing Cx43 or Cx26 [32] were cultured under optimal conditions (see supplementary methods) 
and were transfected with relevant plasmid DNA for 24 h.  Transfection efficiency was 30-50%, 
assessed by GFP or mCherry auto fluorescence. 
Cells were treated as required with the Cx channel blocker 18 glycyrrhetinic acid (18αGA) (25µM, 
Sigma) for the duration of the experiment. Thapsigargin (1M, Sigma) was added for 8h prior to RNA 
and protein extraction to induce ER stress where appropriate. 
 
2.3 Immunofluorescence 
Cells were fixed in either ice-cold methanol or 4% (w/v) paraformaldehyde (as per antibody 
requirements) and processed for immunocytochemical analysis as previously described using a panel 
of antibodies (see supplementary information) [33].  
mCherry or GFP autoflourescence determined localisation of Cx-tagged proteins. Imaging 
was carried out using a Leica TCS SPE confocal laser scanning ﬂuorescence microscope 
(Leica DMRBE, Mannheim, Germany) or a Zeiss Axiovert microscope linked up to an 800 
Airyscan confocal system. Images were acquired under similar conditions and magnifications 
and were processed with ImageJ software, version 1.43 (http://rsbweb.nih.gov/ij/) and Adobe 
Photoshop. 
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2.4 Protein interactions 
HeLa cells selected to stably express Cx31WT-GFP (HeLa31-GFP cells) were transfected with either 
Cx31WT or Cx31G45E tagged to myc-myc-6xHis. The expression vector eGFP-N1 and a control myc-
tagged expression vector were transfected as a positive control for the Western blots.  Transfected 
cells were harvested in NP40 lysis buffer (150mM NaCl, 250mM Tris-HCl (pH 7.3) and 1% (v/v) NP40). 
To 50µl His Mag Sepharose Ni beads (GE Healthcare Life Sciences, Diegem, Belgium) 500µg total 
protein was added. The bead and protein mix was incubated at 4°C overnight with agitation. Non-
bound protein was removed by washing (250 mM NaCl, 250 mM Tris-HCl, 5 mM Imidazol, 0.1 % (v/v) 
NP40), followed by elution of bound protein in elution buffer (500 mM NaCl, 250 mM Tris-HCl, 500 
mM Imidazol and 0.1% (v/v) NP40).   
HeLa43 cells were also transfected with either Cx31WT or Cx31G45E tagged to GFP and were 
harvested in RIPA buffer (125 mM NaCl, 5 mM EDTA, 1% (w/v) Sodium Deoxycholate and 0.5% (v/v) 
Triton X-100). Twenty-five l of sheep anti-rabbit IgG Dynabeads (Thermofisher scientific, UK), 
previously incubated with polyclonal rabbit - GFP antibody (1:100, Abcam, UK), was then added to 
500 μg of total protein and incubated at 4°C overnight with agitation. The beads were extensively 
washed to remove any non-specifically bound proteins and interacting proteins finally eluted in 5x 
Laemmli buffer following manufactures instructions. 
 
2.5 Western blotting 
Protein (30 g) was subjected to SDS-PAGE, and Western blot analysis was performed according to 
standard procedures and blots were probed with appropriate antibodies (please see supplementary 
information).   
 
2.6 Quantitative Reverse-transcriptase PCR (qRT-PCR) 
Total RNA was isolated from transfected HeLa cells using ISOLATE II RNA Mini Kit according to 
manufacturers’ instructions (Bioline) and cDNA synthesised with the M-MLV reverse transcription kit 
(Promega, Southhampton, UK). Primers against CHOP, GADD34 and the reference gene GAPDH were 
used in Taqman PCR reactions (Primer design).  The reaction was performed in a Applied Biosystems 
ViiATM7 Real time PCR system under the following cycling conditions: 95°C for 15 min, followed by 40 
cycles of 95°C for 15 s and 60°C for 30 s. Gene expression levels were obtained from the value of 
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threshold cycle (Ct) for each specific gene and normalised against the Ct of GAPDH (∆∆CT method) 
[34]. 
 
2.7 Propidium Iodide (PI) uptake assays and FACS analysis  
Transfected cells were pre-treated with 18GA as required prior to trypsinisation and resuspension 
in PBS for analysis using a BD FACSCantoII. For each population 20,000 events were gated. To ensure 
only transfected (GFP expressing) cells were counted, cells were gated to FITC using a 488nm laser. 
Fluorescence was detected using a 530/30 fluorochrome set at 400V. Forward and side scatter were 
detected at 340V and 450V respectively. For PI uptake assays the cells were prepared as above then 
incubated with 40µg/ml PI for 1h, on ice, prior to analysis. PI was detected using a 575/26 
fluorochrome set at 300V, in the 488nM gated cells. A control necrotic cell population was prepared 
by freeze-thawing cells three times prior to analysis. Analysis was carried out using Flowing Software 
(http://www.flowingsoftware.com,  v2.5.1). 
 
2.8 Statistical Analysis 
Experiments were performed in triplicate and compiled using GraphPad Prism6 software. Results are 
expressed as mean ± S.E.M and statistical analysis performed using unpaired t-test, and Dunnett’s 
multiple comparison test as appropriate. ** P<0.05; ***P<0.001. 
 
RESULTS 
3.1 Expression of the mutation Cx31G45E causes a unique cellular morphology in vitro and impacts 
intracellular components 
Cx31WT-GFP trafficked to the plasma membrane and assembled into typical gap junction plaque-like 
structures in HeLa Ohio cells (Figure 1A). In contrast, Cx31G45E-GFP accumulated within the 
cytoplasm in pronounced vacuole-like structures (Figure 1B). Co-staining with an antibody against 
SERCA2b (sarcoplasmic reticulum calcium ATPase) showed a diffuse ER distribution in all non-
transfected cells and in cells transfected to express Cx31WT-GFP (Figure 1A and B and 
supplementary Figure 1). By contrast, in Cx31G45E-GFP expressing HeLa cells, SERCA2b co-localised 
with the mutant protein suggesting that the vacuoles are formed from the ER (Figure 1B). The 
microtubule network (Figure 1D) was disrupted in cells expressing Cx31G45E, with evidence of 
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microtubule collapse and bundling in the periphery of the cell in contrast to the stable microtubule 
network in Cx31WT-GFP cells (Figure 1C and 1D (red cells only)). However, the nuclear pore complex 
(Figure 1E and F) and nuclear envelope (Supplementary Figure 2U-X and Y-BB) were not affected by 
expression of Cx31G45E. Other intracellular organelles were also disrupted including the ERGIC, 
Golgi apparatus and proteasomes, all key waystations in the Cx life cycle (Supplementary Figure 2E-
T).  
To determine whether the observed Cx31G45E phenotype was mutation- or residue- specific, a 
number of different mutations were introduced to residue 45 (summarised in Table 1, 
supplementary data). Glycine was either deleted (delG45, Supplementary Figure 3C), replaced with 
alanine (G45A, Supplementary Figure 3D), lysine (G45K, Supplementary Figure 3E), glutamine (G45Q, 
Supplementary Figure 3F), serine (G45S, Supplementary Figure 3G), or tryptophan (G45W, 
Supplementary Figure 3H). Each mutation caused the same morphological change as observed in 
cells expressing Cx31G45E; however, in the case of G45A and G45K the effect was less pronounced 
and clear gap junction plaques were visible.  
 
3.2 Cx31G45E impacts on the spatial localisation of Cx43 and is a dominant mutation 
Cx31 mutations associated with EKV are reported to be dominant-negative. We assessed the impact 
of the mutant Cx31 protein on the intracellular localisation of wild-type connexins expressed in the 
epidermis. Co-transfection of HeLa cells with Cx31G45E-GFP and Cx31WT-mCherry (Figure 2A) and 
Cx30.3 (Figure 2B) resulted in co-localisation of the wild type protein and Cx31G45E in gap junction-
like plaque structures, however, the wild-type protein was also held in vesicular structures within 
the cytoplasm (Figure 2A and B).  The impact of Cx31G45E on the spatial localisation of Cx26 and 
Cx43 was also assessed in HeLa cells stably expressing Cx43 or Cx26. Wild-type Cx31 co-localised at 
the plasma membrane in gap junction plaques with both Cx43 and Cx26 (Supplementary Figure 4A 
and B). In HeLa26 cells transfected with Cx31G45E the mutant protein still accumulated in vacuoles 
and perinuclear regions, however punctate staining of Cx26 at the plasma membrane was evident 
(Figure 2C). By contrast, in HeLa43 cells Cx43 co-localised extensively with the Cx31G45E in the 
vacuolated ER, with limited localisation at the plasma membrane (Figure 2D). This coincided with the 
collapse of the microtubule network in Cx31G45E expressing cells. Cx31G45E produced a similar 
phenotype in keratinocytes where it was trapped in perinuclear regions and in vacuole-like 
structures and co-localised with Cx43, furthermore, the localisation of Cx43 at the plasma 
membrane was markedly reduced. (Figure 2E and F). Wild-type Cx31GFP co-localised extensively 
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with endogenously expressed Cx43, both in intracellular stores, typically around the ERGIC region of 
the cell and in gap junction plaques. Thus the wild-type proteins did not rescue the accumulation of 
Cx31G45E in vesicular structures within the cytoplasm, and there was reduced formation of GJ 
plaques by the wild-type proteins, suggesting that Cx31G45E has a dominant effect. This was most 
evident for Cx43. 
 
3.3 Formation of heteromeric Connexons 
To confirm that the observed co-localisation of Cx31G45E with wild-type Cx31 and Cx43 represented 
protein-protein interactions, nickel pull-down and immunoprecipitation assays were performed. 
HeLa cells transfected to express Cx31WT- and Cx31G45E- GFP-tagged proteins expressed a protein 
of 57kD, while myc-myc-6xHis-tagged proteins were ~33kDa (Figure 3A, con+31myc, 
con+GFP+31myc and H31-GFP input lanes). Nickel pull-down assays determined that Cx31WT-GFP 
interacted with Cx31WT-myc-myc-6xHis, as well as with Cx31G45E-myc-myc-6xHis (Figure 3A, H31-
GFP +31-myc and H31-GFP + G45E-myc lanes respectively). Thus Cx31G45E forms channels with 
Cx31WT. 
To further probe Cx31 interactions with epidermal connexins we also performed 
immunoprecipitation assays to study the interaction of Cx31 and Cx31G45E with Cx43. These 
experiments were performed in HeLa cells stably expressing Cx43 (Figure 3B). The IgG beads were 
coated with a GFP antibody enabling co-immunoprecipitation with proteins associating with the GFP 
tagged connexin. Western blot analysis of the co-IP assays detected eGFP (28kD) from control HeLa 
cells transfected to express eGFP. In HeLa43 cells transfected to express the Cx31-GFP constructs a 
band of ~57kD, representative of the Cx31-GFP protein was detected (Figure 3 B, IP: GFP). The blot 
was also probed for Cx43. In the case of the HeLa cells transfected to express eGFP no Cx43 was 
detected. By contrast, for HeLa43 cells transfected with wild-type or mutant Cx31, Cx43 co-
immunoprecipitated with the Cx31 constructs (Figure 3B, IP: Cx43). These results indicate that Cx31 
and Cx31- G45E can co-oligomerise with Cx43.  
 
3.4 Cx31G45E expression is associated with necrotic cell death but does not induce ER stress  
Previous reports suggest Cx31-EKV associated mutations induce ER stress [27, 29, 30]. Real–time RT-
PCR determined that there was no significant increase in the expression of CHOP/BiP or GADD34, 
genes associated with UPR and ER stress in HeLa cells expressing either pEGFP-N1, Cx31WT-GFP or 
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Cx31G45E-GFP (Figure 4A). By contrast, thapsigargin, a known ER stress inducer, significantly 
induced expression of CHOP by 4.7 ± 0.8 fold and GADD34 by 7.2 ± 0.9 fold (P<0.001). Western blot 
analysis revealed no change in the level of expression of BiP in HeLa cells (Figure 4B) and in HaCaT 
cells no changes in the level of BiP or GADD34 were observed (Figure 4C).  These observations 
suggest that expression of Cx31G45E-GFP does not induce ER stress, and other factors must be 
driving the observed ER changes and the localisation of the mutant protein.  
Finally, to determine if the gross changes occurring in cellular integrity in cells expressing Cx31G45E 
were associated with apoptosis or necrosis, FACS analysis and propidium iodide (PI) uptake assays in 
the presence or absence of 18GA, a connexin channel blocker, were performed (Figure 4D and 
Supplementary Figure 5). Cells were subjected to FACS analysis and under non-transfected control 
conditions, ~4% of the population exhibited a necrotic profile compared to ~70% of cells from the 
induced necrotic population (Figure 4D and supplementary Figure 5). Using the FACS parameters 
established in control conditions, ~6% of cells transfected with pEGFP-N1 and ~4% of cells 
transfected to express Cx31WT-GFP were detected in the necrotic quadrant (Figure 4E). By contrast, 
~25% of cells expressing Cx31-G45E-GFP were necrotic and the effect was not significantly reduced 
by co-treatment with 18GA to block hemichannel activity (Figure 4E). Thus the Cx31G45E 
expressing cells showed a statistically significant (p<0.05) necrotic profile compared to cells 
expressing wildtype Cx31. Integrity of the cell membrane was also examined via PI uptake assays. 
Under non-transfected conditions, cells subject to necrosis exhibited a PI(bright) peak that was absent 
in the control population. In gated, GFP expressing cells a PI(bright) peak was also observed in cells 
expressing Cx31G45E-GFP, but was absent from cells expressing Cx31WT-GFP or pEGFP-N1. This 
PI(bright) peak was marginally, but not significantly reduced in the Cx31G45E-GFP populations treated 
with 18GA. This suggests that the observed permeability to PI is not due to ‘leaky connexin 
channels’ and that the Cx31G45E cells have a compromised membrane (Supplementary Figure 6). 
 
3. Discussion  
The present work details the importance of the amino acid position G45 in Cx31 in maintaining cell 
function and suggests that altered interaction with Cx43 is associated with the pathology of EKV-P. 
Cx mutations associated with skin disease can alter the connexin life cycle in two primary ways. 
Firstly, mutations modify trafficking to the plasma membrane. For example, the EKV-P associated 
mutations G12R, G12D and F137L cause the connexins to be sequestered within the cytoplasm, with 
loss of channel function [35-37]. Secondly, mutant proteins target the plasma membrane but form 
‘leaky hemichannels’ commonly considered as gain-of-function mutations. This includes a variety of 
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Cx26 mutations, including Cx26G45E, associated with the inflammatory skin disease Keratitis 
Ichthyosis Deafness syndrome (KID) [38, 39].   
Mutations introduced to Cx31G45 cause a unique phenotype, with the mutant protein sequestered 
within the ER in vesicular structures. All the EKV mutations reported to date cause abnormal Cx31 
trafficking with the mutant proteins accumulating in intracellular stores, particularly the ER [27-29, 
36, 38-40] (summarised in supplementary Table 1). This is the first report of extensive disruption of 
the ER and microtubule network subsequent to a Cx31 mutation. A number of trafficking mutations 
are also associated with Cx26, with the mutant protein trapped in the ER/Golgi environs, e.g. D66H 
associated with Vohwinkel syndrome and H73R associated with palmoplantar keratoderma [10, 12]. 
A recent report suggests that the H73R mutation may interact with Cx43 channels, inducing changes 
in the functional status of Cx43 [41]. Other mutations in Cx26, primarily associated with the amino 
terminal domain and the first part of first extracellular loop, are linked with KID syndrome. Recent 
studies indicate that a variety of Cx26 mutations have trans-dominant effects on other epidermal 
connexins, including Cx43, inducing altered heteromeric channel function [41-43].  
Connexin 31 is expressed in the skin with a similar profile to that of Cx43 [44]. Previous studies have 
suggested that Cx31 and Cx43 do not form functional heteromeric channels [45].  However, an 
ability of these channels to functionally interact has been hinted at in a number of studies. In the 
skin of Cx43 deficient mice, Cx31 was significantly down-regulated and associated with enhanced 
rates of wound closure [44]. A EKV-mouse model for the mutation Cx31F137L revealed that 
homozygous mice were non-viable, but that the heterozygous mice had similar wound healing 
capacities to the Cx43 conditional knockout mice, suggesting functional interactions between these 
two proteins [23]. In the present work, we observed that Cx43 and Cx31 strongly co-localised at 
regions of cell to cell contact in both HeLa43 cells and HaCaT cells. Immunoprecipitation assays 
confirmed the interaction of these two proteins. In both HeLa43 and HaCaT cells expressing the 
Cx31G45E mutation Cx43 co-localised with the mutation, being trapped inside the cell in the 
associated G45E-like vacuoles, suggesting a trans-dominant effect. Rapid remodelling and turnover 
of Cx43/Cx31 proteins and differing levels of heteromeric interaction could account for altered 
cellular signalling and the transient keratosis and erythema associated with EKV, although such 
speculations require further analysis. 
The effect of Cx31G45E expression in vitro was very different to that reported for Cx26G45E and 
other non-trafficking mutations in Cx31 and Cx26, with pronounced disruption of the ER. The amino 
acid G45, located on the first extracellular loop of connexins, is highly conserved among all Cx 
subtypes.  Structural analysis for Cx26 revealed the importance of G45 in lining the extracellular 
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funnel, suggesting that this amino acid is critical for channel function [46]. Zhang et al. examined the 
G45E mutation in Cxs30, 32 and 43 and showed that cell death occurred within 24 h of transfection, 
which could be rescued by incubating cells in >5 mM Ca2+ [47], suggesting that G45 is a common 
calcium sensing centre for connexins. Each of the amino acid substitutions in the present study 
introduced subtle changes to properties at this position. While G45E introduces an acidic residue, 
G45K and G45S mutations result in a change in charge to positive and neutral amino acids 
respectively.  The G45K mutation induced a negative to positive charge while introduction of 
glutamine results in a change in the size of the amino acid and introducing tryptophan (G45W) 
causes a switch from a hydrophilic to a hydrophobic amino acid. All these amino acid changes, 
including deletion of G45, deregulated Cx31 transport. By contrast, Zhang et al. showed that a G45E 
mutation in Cxs43 and 32 had no effect on protein trafficking. Although the mutation Cx26G45E is 
associated with a lethal form of KID, little alteration in spatial localisation of the protein has been 
reported, however leaky hemichannels form that are extremely sensitive to changes in calcium 
levels [48, 49]. Thus our data clearly illustrates the importance of the glycine at position 45 in 
maintaining Cx31 structure.  
Connexin trafficking relies on an intact microtubule network, with plus end tracking motor proteins 
and partners such as consortin required for efficient membrane delivery [50, 51]. We observed a 
profound re-localisation of Cx43 with Cx31G45E, suggesting a trans-dominant effect on Cx43 
trafficking. It is well established that Cx43 trafficking is highly dependent on an intact microtubular 
network and further studies are now required to determine how heteromeric mutant channels may 
interact with transport networks [50, 51] . 
ER stress and an unfolded protein response (UPR) have been reported in several EKV-P mutations 
and are key events in inducing necrotic cell death [27-29, 36, 40]. Although our studies showed no 
evidence of ER stress, FACS analysis and PI uptake assays determined that the mutation induced 
necrotic cell death, an endpoint also observed for the other EKV-P mutations and highly likely linked 
to altered keratinization [52]. The lack of ER stress could be attributed to a breakdown of the 
microtubule network, required for maintaining ER structure [53], suggesting this may be an early 
event following expression of the mutant protein. 
Our observations suggest that diverse, mutation-specific mechanisms lead to necrotic cell death 
associated with the EKV-P phenotype. In cells expressing the mutation Cx31R42P, induced ER stress 
promoted production of reactive oxygen species (ROS), which stimulated hemichannel activity and 
promoted cell death [27]. Hemichannel blockers or high extracellular calcium decreased the level of 
cell death. Interestingly, the cell death phenotype was promoted when the cells were grown at low 
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temperature (26oC). Tang and colleagues [28] reported that the trafficking deficiency and loss of 
function of mutations Cx31-G12D, R42P and F137L was recovered by culturing cells at 27oC. These 
authors also reported that BiP/Hsp70 and cFos-JunB pathways are central in EKV. A further Cx31 
mutation V174M, associated with non-syndromic deafness but with no skin pathology reported, 
accumulated in lysosomes and the ER [54]. This mutation also formed non-functional channels and 
had a trans-dominant effect on the trafficking of Cx26 but did not alter the ability of WTCx31 to 
assemble at the plasma membrane.   
In conclusion, four clinical reports indicate that G45E is associated with EKV-P. To our knowledge, 
our report is the first to detail the impact of this mutation on cellular integrity and provides evidence 
that disease progression is associated with necrotic cell death. We also show that the mutation has a 
trans-dominant effect on the trafficking of Cx43 which, together with recent data for Cx26 [42, 43], 
suggest altered interaction with Cx43 may be indicative of severe Cx-related skin disorders. Although 
the EKV-P phenotype associated with this mutation is similar to other EKV-P mutations reported it is 
clear that the underlying mechanism attributed to the mutation is different, suggesting variable 
mechanisms of triggering the disease state and warrants further investigation.  
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